These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 9865094)

  • 1. [Recommended article of the month: Effects of intensive blood-pressure lowering and low-dose aspirin in patients with hypertension: principal results of the hypertension optimal treatment (HOT) randomised trial].
    Maldonado J
    Rev Port Cardiol; 1998 Oct; 17(10):843-4. PubMed ID: 9865094
    [No Abstract]   [Full Text] [Related]  

  • 2. The Hypertension Optimal Treatment study and the importance of lowering blood pressure.
    Hansson L
    J Hypertens Suppl; 1999 Feb; 17(1):S9-13. PubMed ID: 10340838
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Effect of intensive antihypertensive treatment and of aspirin in a low dose in the hypertensive. The HOT (Hypertension Optimal Treatment) study].
    Mallion JM; Benkritly A; Hansson L; Zanchetti A
    Arch Mal Coeur Vaiss; 1999 Aug; 92(8):1073-8. PubMed ID: 10486668
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Do intensive blood pressure lowering and low-dose ASA help our hypertensive patients?
    Evans MF
    Can Fam Physician; 1998 Dec; 44():2655-7. PubMed ID: 9870118
    [No Abstract]   [Full Text] [Related]  

  • 5. Hypertension Optimal Treatment (HOT) trial.
    Parving HH
    Lancet; 1998 Aug; 352(9127):574-5. PubMed ID: 9716085
    [No Abstract]   [Full Text] [Related]  

  • 6. Influence of gender on prevention of myocardial infarction by antihypertensives and acetylsalicylic acid: the HOT study.
    Kjeldsen SE; Warnold I; Hansson L;
    J Gend Specif Med; 2000; 3(8):35-8. PubMed ID: 11253266
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Increased blood pressure should be efficiently treated. Results from the Hypertension Optimal Treatment Study (the HOT-study)].
    Ibsen H
    Ugeskr Laeger; 1998 Jun; 160(25):3743-5. PubMed ID: 9641064
    [No Abstract]   [Full Text] [Related]  

  • 8. [Spanish contribution to the HOT (Hypertension Optimal Treatment) study. Final results. Spanish Investigators in the HOT study].
    Suárez C; Cucala M; Coca A; Ruilope LM
    Med Clin (Barc); 1999 Oct; 113(10):361-5. PubMed ID: 10562937
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Antihypertensive treatment preceding cerebrovascular diseases is insufficient according to recommendations].
    Nielsen AA; Christensen C; Brandslund I; Eriksen EW; Schmitz A
    Ugeskr Laeger; 2008 Oct; 170(41):3246-50. PubMed ID: 18940158
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Calcium antagonists in cardiovascular disease. Clinical evidence from morbidity and mortality trials].
    Oparil S; Bakir SE
    Drugs; 2000; 59 Spec No 2():25-37. PubMed ID: 11002856
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hypertension Optimal Treatment (HOT) trial.
    Grossman E; Goldbourt U
    Lancet; 1998 Aug; 352(9127):572; author reply 574-5. PubMed ID: 9716080
    [No Abstract]   [Full Text] [Related]  

  • 12. [The effect of aspirin on rheological properties of erythrocytes in essential hypertension].
    Korbut RA; Adamek-Guzik T
    Przegl Lek; 2002; 59(2):71-5. PubMed ID: 12152252
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Efficacy and tolerability of combination therapy with valsartan plus hydrochlorothiazide compared with amlodipine monotherapy in hypertensive patients with other cardiovascular risk factors: the VAST study.
    Ruilope LM; Malacco E; Khder Y; Kandra A; Bönner G; Heintz D
    Clin Ther; 2005 May; 27(5):578-87. PubMed ID: 15978306
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Current trends in the treatment of hypertension.
    Wasir HS; Agarwal R
    J Assoc Physicians India; 1993 Nov; 41(11):725-30. PubMed ID: 8005931
    [No Abstract]   [Full Text] [Related]  

  • 15. [Disturbances in aggregability of red blood cells in essential hypertension].
    Korbut RA; Adamek-Guzik T
    Folia Med Cracov; 2005; 46(1-2):3-19. PubMed ID: 17037284
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Results of a phase III, 8-week, multicenter, prospective, randomized, double-blind, parallel-group clinical trial to assess the effects of amlodipine camsylate versus amlodipine besylate in Korean adults with mild to moderate hypertension.
    Kim SH; Kim YD; Lim DS; Yoon MH; Ahn YK; On YK; Lee JW; Kim IJ; Park JB; Kim JJ; Chung WS; Yang JY; Seo HS; Shin EK; Kim HS;
    Clin Ther; 2007 Sep; 29(9):1924-36. PubMed ID: 18035192
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ambulatory blood pressure-lowering effects of valsartan and enalapril after a missed dose in previously untreated patients with hypertension: a prospective, randomized, open-label, blinded end-point trial.
    Hermida RC; Ayala DE; Khder Y; Calvo C
    Clin Ther; 2008 Jan; 30(1):108-20. PubMed ID: 18343247
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Does treatment of non-malignant hypertension reduce the incidence of renal dysfunction? A meta-analysis of 10 randomised, controlled trials.
    Hsu CY
    J Hum Hypertens; 2001 Feb; 15(2):99-106. PubMed ID: 11317188
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Metabolic and clinical outcomes in nondiabetic individuals with the metabolic syndrome assigned to chlorthalidone, amlodipine, or lisinopril as initial treatment for hypertension: a report from the Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT).
    Black HR; Davis B; Barzilay J; Nwachuku C; Baimbridge C; Marginean H; Wright JT; Basile J; Wong ND; Whelton P; Dart RA; Thadani U;
    Diabetes Care; 2008 Feb; 31(2):353-60. PubMed ID: 18000186
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Old or new antihypertensive drugs? Consequences from ALLHAT. Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial].
    Düsing R
    Dtsch Med Wochenschr; 2003 Jan; 128(5):214-6. PubMed ID: 12557115
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.